Sign Out
Hypersensitivity to anagrelide or any of the excipients of the medicinal product.
Patients with moderate or severe hepatic impairment.
Patients with moderate or severe renal impairment (creatinine clearance <50 mL/min).
UserName
Profession Email
Profession Email
Continue with Google